Close Menu

sequencing-based diagnostics

NEW YORK (GenomeWeb) − Competition for non-invasive prenatal testing in Germany is heating up, with Illumina announcing this week that it has teamed up with a German diagnostic laboratory and other European labs to transfer Verinata's test technology to those countries, and LifeCodexx saying last

NEW YORK (GenomeWeb) – Appistry said today that it has signed a deal to include Personal Genome Diagnostics' CancerSelect panel in the recently released Appistry CloudDx genomics testing service.

NEW YORK (GenomeWeb) – N-of-One today said that it will provide OncoDNA with clinical interpretation services for its next-generation sequencing and other molecular tests for patients throughout Europe.

NEW YORK (GenomeWeb News) – Sequenom said in a regulatory filing today that the US Patent and Trademark Office, Patent Trial and Appeal Board has made rulings favorable to the company in an ongoing dispute with Verinata Health regarding noninvasive prenatal testing technologies.

NEW YORK (GenomeWeb News) – CollabRx announced today that The Jackson Laboratory will incorporate the firm's data analysis solutions into genetic sequencing-based cancer tests that the lab offers to physicians.

This article has been corrected to reflect that Illumina will seek Chinese FDA approval for a MiSeqDx-based NIPT assay, not a HiSeq2500-based assay, as previously reported.

NEW YORK (GenomeWeb News) – Alliance Global today said that it has signed an agreement with Amgen to provide cancer mutation testing in certain countries in the Middle East and Africa.

NEW YORK (GenomeWeb News) – Ariosa Diagnostics today said that it has inked a deal with a subsidiary of Sonic Healthcare to offer the firm's Harmony Prenatal Test in Germany.

NEW YORK (GenomeWeb News) – The government of Ontario recently announced about C$7 million (US$6.7 million) in new funding for four large-scale genomics projects.

NEW YORK (GenomeWeb News) – A shareholder is suing Sequenom and its board, alleging they breached their fiduciary duty and damaged the company by implementing an illegal strategy to drive up orders of the MaterniT21 Plus non-invasive prenatal diagnostic test.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.